Arsenic inhibition of telomerase transcription leads to genetic instability

W C Chou1, A L Hawkins, J F Barrett

  • 1Program in Human Genetics and Molecular Biology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Insights

Arsenic exposure causes chromosomal abnormalities and inhibits human telomerase (hTERT) gene transcription, potentially explaining its dual role as both a cancer treatment and carcinogen.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Arsenic compounds are utilized in treating acute promyelocytic leukemia.
  • Arsenic also exhibits carcinogenic properties, presenting a paradoxical effect.
  • Understanding arsenic resistance mechanisms in leukemia is crucial.

Purpose of the Study:

  • To elucidate the mechanism of arsenic resistance in the NB4 leukemia cell line.
  • To investigate the impact of arsenic exposure on chromosomal stability and telomerase activity.
  • To explain the paradoxical carcinogenic and antitumor effects of arsenic.

Main Methods:

  • Exposure of NB4 leukemia cells to arsenic.
  • Analysis of chromosomal abnormalities, specifically end-to-end fusions.
  • Assessment of human telomerase reverse transcriptase (hTERT) gene transcription.
  • Evaluation of c-Myc and Sp1 transcription factor activities.

Main Results:

  • Arsenic exposure induced chromosomal abnormalities, predominantly end-to-end fusions.
  • Arsenic was found to inhibit hTERT gene transcription.
  • Decreased activity of c-Myc and Sp1 transcription factors was observed.
  • Inhibition of telomerase activity leads to chromosomal end lesions.

Conclusions:

  • Arsenic-induced inhibition of human telomerase (hTERT) transcription, possibly via reduced c-Myc and Sp1 activity, contributes to chromosomal instability.
  • This chromosomal instability may drive either cancer cell death or genomic instability and carcinogenesis.
  • The findings provide a molecular basis for arsenic's dual role in cancer therapy and carcinogenesis.

Related Concept Videos

Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Replication in Eukaryotes01:29

Replication in Eukaryotes

In eukaryotic cells, DNA replication is highly conserved and tightly regulated. Multiple linear chromosomes must be duplicated with high fidelity before cell division, so there are many proteins that fulfill specialized roles in the replication process. Replication occurs in three phases: initiation, elongation, and termination, and ends with two complete sets of chromosomes in the nucleus.
Many Proteins Orchestrate Replication at the Origin
Eukaryotic replication follows many of the same...
Telomeres and Telomerase02:41

Telomeres and Telomerase

In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).